Yanchen Li
Senior Director, Pharmaceutical Collaboration Genetron Health
Seminars
Thursday 25th September 2025
Regulation Consideration of CTA & CDx Strategy Across US-China in MRCT
11:00 am
- Understanding CTA and CDx regulation environment in china and beyond
- Understanding IVD and CDx commercialization and payment environment in China
- Regulation strategy and Dx choice in MRCT
- Genetron Global: Advancing MRD detection (heme and solid tumors) and cross border CTA to CDx solutions
